Search results

Articles (6)

Journals (0)

1-6 of 6 results for PWRM

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published July, 2025

Delphi panel to understand the real-world occurrence and management of ofatumumab injection-related reactions among healthcare providers of people with relapsing multiple sclerosis

Shiv Saidha, John Kramer, Brandon Brown [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Restricted accessEditorialFirst published May, 2025

The availability of common patient-reported outcome measures in hand surgery across Europe

Martin Aman, Anna Pennekamp, Cosima Prahm [...]

Journal of Hand Surgery (European Volume)

Open accessResearch articleFirst published October, 2018

Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis

Dayo Afolabi, Christo Albor, Lukasz Zalewski [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published April, 2026

De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy

Annette M Langer-Gould, Jessica B Smith, Allen Scott Nielsen [...]

Multiple Sclerosis Journal

Open accessResearch articleFirst published April, 2026

Long-term outcomes of autologous haematopoietic stem cell transplantation in multiple sclerosis: A retrospective single-centre experience

Simona Malucchi, Marco De Gobbi, Maria Malentacchi [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open accessResearch articleFirst published 2025

Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study

Klaus Schmierer, Heinz Wiendl, Frederik Barkhof [...]

Therapeutic Advances in Neurological Disorders

Search results

Articles (6)

Journals (0)

1-6 of 6 results for PWRM

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published July, 2025

Delphi panel to understand the real-world occurrence and management of ofatumumab injection-related reactions among healthcare providers of people with relapsing multiple sclerosis

Shiv Saidha, John Kramer, Brandon Brown [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Restricted accessEditorialFirst published May, 2025

The availability of common patient-reported outcome measures in hand surgery across Europe

Martin Aman, Anna Pennekamp, Cosima Prahm [...]

Journal of Hand Surgery (European Volume)

Open accessResearch articleFirst published October, 2018

Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis

Dayo Afolabi, Christo Albor, Lukasz Zalewski [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published April, 2026

De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy

Annette M Langer-Gould, Jessica B Smith, Allen Scott Nielsen [...]

Multiple Sclerosis Journal

Open accessResearch articleFirst published April, 2026

Long-term outcomes of autologous haematopoietic stem cell transplantation in multiple sclerosis: A retrospective single-centre experience

Simona Malucchi, Marco De Gobbi, Maria Malentacchi [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open accessResearch articleFirst published 2025

Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study

Klaus Schmierer, Heinz Wiendl, Frederik Barkhof [...]

Therapeutic Advances in Neurological Disorders